Managing Comorbidities, Determinants and Disability at Start and End of TB Treatment under Routine Program Conditions in China

Author:

Liu Yuhong12,Lin Yan3ORCID,Sun Yuxian12,Thekkur Pruthu34ORCID,Cheng Changhao5,Li Yuecui6,Shi Yunzhen7,Jiang Jun8,Liao Jiong9,Nie Chuangui10,Sun Wenyan11,Liang Chengyuan12,Zhang Xiaojuan13,Liu Sang14,Ma Yan15,Berger Selma Dar3,Satyanarayana Srinath34ORCID,Kumar Ajay M. V.3416ORCID,Khogali Mohammed17,Zachariah Rony18ORCID,Golub Jonathan E.19,Li Liang12,Harries Anthony D.320ORCID

Affiliation:

1. Beijing Chest Hospital, Capital Medical University, No. 9 Beiguan Ave, Tongzhou, Beijing 101149, China

2. Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing 101149, China

3. International Union Against Tuberculosis and Lung Disease, 2 Rue Jean Lantier, 75001 Paris, France

4. The Union South-East Asia Office, C-6 Qutub Institutional Area, New Delhi 110016, India

5. Wuhan Pulmonary Hospital, No. 28 Baofengyilu, Qiaokou, Wuhan 430000, China

6. The First People’s Hospital of Yongkang, No. 599 Jinshan West Road, Yongkang 321300, China

7. Dongyang People’s Hospital, No. 60 Wuning West Road, Dongyang 322100, China

8. The Third People’s Hospital of Yichang City, No. 32 Gangyaolu, Yichang 443000, China

9. The People’s Hospital of Laiban, No. 159 Pangudadao, Laiban 546100, China

10. Xiangyang Institute of Tuberculosis Control and Prevention, No. 20 Xinhuala, Xiangyang 441000, China

11. Ezhou Third Hospital, No. 16 Minxin West Road, Ezhou 436000, China

12. Baise City People’s Hospital, No. 8 Chengxianglu, Youjiang, Baise 533000, China

13. Zhongwei People’s Hospital, Gulouxijie, Zhongwei 755000, China

14. Guangxi Chest Hospital, No. 8 Yangjiaoshanlu, Yufeng, Liuzhou 545000, China

15. The People’s Hospital of Tongxin, Xueyuanlu, Tongxi, Yuhaizhen 751100, China

16. Yenepoya Medical College, Yenepoya (Deemed to be University), Mangalore 575018, India

17. Institute of Public Health, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain 17666, United Arab Emirates

18. UNICEF, UNDP, World Bank, World Health Organization, Special Programme for Research and Training in Tropical Diseases (TDR), Avenue Appia 20, 1211 Geneva, Switzerland

19. Johns Hopkins Center for Tuberculosis, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA

20. Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK

Abstract

Many patients with tuberculosis (TB) have comorbidities, risk determinants and disability that co-exist at diagnosis, during and after TB treatment. We conducted an observational cohort study in 11 health facilities in China to assess under routine program conditions (i) the burden of these problems at the start and end of TB treatment and (ii) whether referral mechanisms for further care were functional. There were 603 patients registered with drug-susceptible TB who started TB treatment: 84% were symptomatic, 14% had diabetes, 14% had high blood pressure, 19% smoked cigarettes, 10% drank excess alcohol and in 45% the 6 min walking test (6MWT) was abnormal. Five patients were identified with mental health disorders. There were 586 (97%) patients who successfully completed TB treatment six months later. Of these, 18% were still symptomatic, 12% had diabetes (the remainder with diabetes failed to complete treatment), 5% had high blood pressure, 5% smoked cigarettes, 1% drank excess alcohol and 25% had an abnormal 6MWT. Referral mechanisms for the care of comorbidities and determinants worked well except for mental health and pulmonary rehabilitation for disability. There is need for more programmatic-related studies in other countries to build the evidence base for care of TB-related conditions and disability.

Funder

NICEF, UNDP, World Bank, World Health Organization, Special Programme for Research and Training in Tropical Diseases

Publisher

MDPI AG

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Immunology and Microbiology

Reference47 articles.

1. World Health Organization (2022). Global Tuberculosis Report 2022, World Health Organization.

2. International Research and Guidelines on Post-Tuberculosis Chronic Lung Disorders: A Systematic Scoping Review;Wanner;BMJ Glob. Health,2018

3. World Health Organization (2022). Framework for Collaborative Action on Tuberculosis and Comorbidities, World Health Organization.

4. Post-Tuberculosis Lung Disease: Clinical Review of an Under-Recognised Global Challenge;Allwood;Respiration,2021

5. An E-Value Analysis of Potential Unmeasured or Residual Confounding in Systematic Reviews of Post-Tuberculosis Mortality, Respiratory Disease, and Cardiovascular Disease;Basham;Ann. Epidemiol.,2022

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3